Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections.
ACE2 peptide
SARS-CoV-2 variants
SERS identification
binding affinity
blocking virus infection
magnetic separation
plasmonic-magnetic heterostructure
Journal
ACS applied bio materials
ISSN: 2576-6422
Titre abrégé: ACS Appl Bio Mater
Pays: United States
ID NLM: 101729147
Informations de publication
Date de publication:
02 Sep 2022
02 Sep 2022
Historique:
entrez:
2
9
2022
pubmed:
3
9
2022
medline:
3
9
2022
Statut:
aheadofprint
Résumé
The emergence of Alpha, Beta, Gamma, Delta, and Omicron variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for several million deaths up to now. Because of the huge amount of vaccine escape mutations in the spike (S) protein for different variants, the design of material for combating SARS-CoV-2 is very important for our society. Herein, we report on the design of a human angiotensin converting enzyme 2 (ACE2) peptide-conjugated plasmonic-magnetic heterostructure, which has the capability for magnetic separation, identification via surface enhanced Raman spectroscopy (SERS), and inhibition of different variant SARS-CoV-2 infections. In this work, plasmonic-magnetic heterostructures were developed using the initial synthesis of polyethylenimine (PEI)-coated Fe
Identifiants
pubmed: 36053723
doi: 10.1021/acsabm.2c00573
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM